Get started
D.Western Therapeutics Institute, Inc.D.Western Therapeutics Institute, Inc.D.Western Therapeutics Institute, Inc.

D.Western Therapeutics Institute, Inc.

No trades
See on Supercharts
Overview
Financials News Discussions Seasonals

6DW chart


Full chart

6DW upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪31.16 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.160 EUR
Net income (FY)
‪−7.93 M‬ EUR
Revenue (FY)
‪2.90 M‬ EUR
Shares float
‪41.02 M‬
Beta (1Y)
−1.06

Employees


Employees (FY)
21
Change (1Y)
0
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About D.Western Therapeutics Institute, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
dwti.co.jp
Headquarters
Nagoya
Founded
2004
ISIN
JP3548740004
FIGI
BBG000PQGYK0
D. Western Therapeutics Institute, Inc. engages in the research and development of pharmaceutical drugs. Its products include ophthalmic solution and agents for anti-platelet and anti-glaucoma. Its research and development laboratory undertakes drug design, screening of compounds, and selection of prospect compounds at early stage of drug research and development process. The company was founded by Hiroyoshi Hidaka on February 26, 1999 and is headquartered in Nagoya, Japan.

Check out other big names from the same industry as 6DW.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

6DW news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange D.Western Therapeutics Institute, Inc. stocks are traded under the ticker 6DW.
6DW reached its all-time high on May 7, 2013 with the price of 25.515 EUR, and its all-time low was 0.265 EUR and was reached on Aug 5, 2024. View more price dynamics on 6DW chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track D.Western Therapeutics Institute, Inc. financials in yearly and quarterly reports right on TradingView.
D.Western Therapeutics Institute, Inc. is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
6DW net income for the last quarter is ‪−981.93 K‬ EUR, while the quarter before that showed ‪−925.30 K‬ EUR of net income which accounts for −6.12% change. Track more D.Western Therapeutics Institute, Inc. financial stats to get the full picture.
No, 6DW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 9, 2025, the company has 21 employees. See our rating of the largest employees — is D.Western Therapeutics Institute, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. D.Western Therapeutics Institute, Inc. EBITDA is ‪−6.01 M‬ EUR, and current EBITDA margin is −245.97%. See more stats in D.Western Therapeutics Institute, Inc. financial statements.
Like other stocks, 6DW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade D.Western Therapeutics Institute, Inc. stock right from TradingView charts — choose your broker and connect to your account.